Pharmafile Logo
Pharmafocus logo
Advanced Search
shutterstock_273326141

Teva and Regeneron team up for $2.6 billion pain treatment development

September 21, 2016
Research and Development, Sales and Marketing Regeneron, Teva, fasinumab, osteoarthritis

Teva and Regeneron have entered an agreement worth up to $2.6 billion to develop and market the latter’s experimental nerve …

News
microsoft-80658_1280

AstraZeneca and Microsoft to develop ‘drag and drop’ cancer simulation

September 21, 2016
Medical Communications, Research and Development AstraZeneca, Digital Pharma Guide, Microsoft

AstraZeneca has entered into a partnership with tech giant Microsoft to develop a new computerised modelling system which promises to …

News
allergan

Allergan expands NASH portfolio with $1.7 billion in acquisitions

September 21, 2016
Research and Development, Sales and Marketing Akarna Therapeutics, Allergan, Tobira Therapeutics, acqusition, nash

Allergan has gone on a spending spree this week, snapping up clinical-stage biotech Tobira Therapeutics and privately-held Akarna Therapeutics for …

News
a_scientist_at_work_at_sanofis_immunology_laboratory_in_thailand

Sanofi reveals promising data for relapsing remitting MS treatment

September 20, 2016
Manufacturing and Production, Research and Development RRMS, Sanofi, relapsing remitting multiple sclerosis, relapsing-remitting multiple sclerosis

Sanofi Genzyme, the speciality care global business unit of the French pharma firm announced six-year investigational data on Lemtrada (alemtuzumab) …

News

Bayer CEO defends $66 billion Monsanto acquisition

September 20, 2016
Manufacturing and Production, Sales and Marketing Bayer, Werner Baumann, monsanto

Bayer AG’s chief executive Werner Baumann has spoken in defence of the company’s move last week to acquire US agricultural …

News
takeda_world

Takeda partners with Zydus to develop chikungunya vaccine

September 20, 2016
Manufacturing and Production, Research and Development Takeda, Zydus Cadila, chikungunya

Zydus Cadila has teamed up with Takeda to develop a vaccine for the chikungunya virus. Zydus Cadila’s group firm Cadila …

News
2363

GSK appoints Emma Walmsley as CEO

September 20, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, GlaxoSmithKline, appointment

GlaxoSmithKline, the UK’s biggest drugs company, has appointed Emma Walmsley as its new CEO. Walmsley will step into the vacancy …

News

Duchenne drug gets FDA approval in “unprecedented” ruling

September 20, 2016
Manufacturing and Production, Sales and Marketing Duchenne Muscular Dystrophy, FDA, sarepta

The FDA has gone against the advice of its own staff to approve the first treatment of Duchenne muscular dystrophy …

News
Ian Parsons

PCI Pharma Services to Share Expertise at Free Serialization Forum

September 19, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing PCI Pharma Services

Leading pharmaceutical outsourcing services provider PCI Pharma Services, in collaboration with Xytnek, Antares, and Healthcare Packaging magazine, will host a …

News
Press release

Ashfield and Patient Connect Form Alliance to Provide Holistic Patient Services

September 19, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ashfield

Ashfield Commercial and Medical Services, part of UDG Healthcare plc, a global leader in providing outsourced healthcare services to pharmaceutical, …

News
Press release
roche__tree

NICE rejects expanded treatment indication for Roche’s Esbriet

September 19, 2016
Sales and Marketing Esbriet, NICE, Roche, rejection

NICE has published a final appraisal rejecting the expanded use of Roche’s Esbriet (pirfenidone) for the treatment of early idiopathic …

News
lilly_entrance_web

EU recommendation for Lilly’s soft tissue cancer drug

September 19, 2016
Sales and Marketing CHMP, EMA, Eli Lilly, Lartruvo, soft tissue sarcoma

The Committee for Medicinal Products for Human Use (CHMP) has recommended Eli Lilly’s Lartruvo (olaratumab) for treatment of adults with …

News
jj_sign_on_wall

J&J in $4.33bn eye surgery unit acquisition

September 19, 2016
Manufacturing and Production, Sales and Marketing Abbott, Johnson & Johnson, acquisition

Johnson & Johnson has agreed to buy Abbott Laboratories’ eye surgery equipment unit in an all-cash deal for £4.33 billion …

News

“First of its kind” manufacturing campus to bring 500 jobs to Ireland

September 19, 2016
Manufacturing and Production, Sales and Marketing GE Healthcare, Ireland, manufacturing

Biopharma firm GE Healthcare has made a major investment to create a ‘BioPark’ in Ringaskiddy, Ireland, set to generate 500 …

News
shutterstock_274590824

Sanofi accuses MSD of US patent infringement

September 19, 2016
Sales and Marketing MSD, Sanofi, lawsuit

Sanofi has filed a suit against MSD in the United States District Court for the District of Delaware accusing the …

News
shutterstock_141299494

Precision medicine reveals ‘Achilles heel’ in chronic myeloid leukaemia

September 16, 2016
Medical Communications University of Glasgow, chronic myeloid leukaemia

Scientists at the University of Glasgow believe they have revealed an ‘Achilles heel’ of chronic myeloid leukaemia (CML), making their …

News
4420456374_64a3d7e6aa

Top Ten articles in the Pharma Industry this week

September 16, 2016
Medical Communications Bayer, GSK, Gilead, GlaxoSmithKline, J&J, JJ, Pfizer, Roche, Sanofi, Takeda, aspen, google, monsanto

As we come to the end of another week, we’re looking back at an exciting week in the industry; there …

News
c_gajus_-_fotolia

Teva and Intel team up to tackle Huntington’s with wearable tech

September 16, 2016
Medical Communications Huntington's, Intel, Teva, wearable tech

Israeli pharma firm Teva is joining forces with technology giant Intel to tackle the debilitating disease Huntington’s with cutting-edge wearable …

News
shutterstock_512649

Dechra signs £31 million acquisition

September 16, 2016
Medical Communications Apex Laboratories, Dechra, acquisition

Dechra has agreed a deal to acquire veterinary pharmaceutical company Australian firm Apex Laboratories for AUS $55 (£31.3) million. The …

News
novo_corp_hq2

Novo Nordisk’s diabetes drug “significantly reduced’ cardiovascular risk

September 16, 2016
Medical Communications Novo Nordisk, diabetes, semaglutide

Novo Nordisk has announced that its diabetes drug semaglutide “significantly reduced” the risk of major cardiovascular events at the 52nd …

News
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026